Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
13.85
+0.42 (3.13%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.

The company’s products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies.

In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services.

The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.

It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents.

The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007.

Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Quanterix Corporation
Quanterix logo
Country United States
Founded 2007
IPO Date Dec 7, 2017
Industry Medical Devices
Sector Healthcare
Employees 441
CEO Masoud Toloue

Contact Details

Address:
Building 1, 900 Middlesex Turnpike
Billerica, Massachusetts 01821
United States
Phone 617 301 9400
Website quanterix.com

Stock Details

Ticker Symbol QTRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001503274
CUSIP Number 74766Q101
ISIN Number US74766Q1013
Employer ID 20-8957988
SIC Code 3826

Key Executives

Name Position
Dr. Masoud Toloue Ph.D. President, Chief Executive Officer and Director
Dr. David R. Walt Ph.D. Co-Founder, Chairman of Scientific Advisory Board and Independent Director
Vandana Sriram CPA Chief Financial Officer and Treasurer
Dr. Michael Miller Ph.D. Chief Operating Officer
Alexandra Phillips Senior Vice President and Chief Information Officer
Laurie A. Churchill Senior Vice President, General Counsel and Secretary
Naren Bhat Senior Vice President of Corporate Development and Strategy
Erica Bell Chief People Officer
Dr. Mark T. Roskey Ph.D. Chief Science and Collaboration Officer
Darrin Crisitello M.B.A. Senior Vice President and Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 4, 2024 8-K/A [Amend] Current report
Oct 3, 2024 8-K Current Report
Aug 21, 2024 8-K Current Report
Aug 8, 2024 10-Q Quarterly Report
Aug 8, 2024 8-K Current Report
Jun 27, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jun 12, 2024 144 Filing
Jun 7, 2024 8-K Current Report
May 31, 2024 SD Form - SD
May 28, 2024 8-K Current Report